Basel Medical Group Ltd Ordinary Shares
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BMGL research report →
Price Chart
About the company
Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.
- CEO
- Yen Feng Chhoa
- IPO
- 2025
- Employees
- 82
- HQ
- Singapore, CE, SG
Get TickerSpark's AI analysis on BMGL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.21M
- P/E
- -12.18
- PEG
- -0.12
- P/S
- 0.47
- P/B
- 1.06
- EV/EBITDA
- -9.07
- Div Yield
- 0.00%
- Gross Margin
- -2.37%
- Op Margin
- -31.66%
- Net Margin
- -67.66%
- ROE
- -173.64%
- ROIC
- -26.92%
Latest fiscal year · YoY change
- Revenue
- $11.32M+12.6%
- Gross Profit
- $8.79M+12.7%
- Op Income
- $-2,183,015
- Net Income
- $-12,087,603-683.2%
- EPS
- $-5.16-554.5%
- OCF Growth
- -273.1%
- FCF Growth
- -275.9%
- 52W High
- $21.72
- 52W Low
- $2.95
- 50D MA
- $4.87
- 200D MA
- $6.83
- Beta
- 0.26
- RSI (14)
- 40
- Avg Volume
- 538.01K
No earnings-call transcripts are available for BMGL yet.
- Free Float
- 27.8%
- Shares Outstanding
- 1.57M
- Float Shares
- 435.95K
of shares held by institutions
3 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Polaris Financial Partners | 1 | ▲ 1 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 2, 26 | Hong Frederick Shieh Ming | other | 0 |
| Jun 5, 26 | Neo Alton Chun How | other | 0 |
| Mar 18, 26 | Soong Kwek Yoon | other | 0 |
| Mar 18, 26 | Lu Jianing JN | other | 0 |
| Mar 18, 26 | CHEN TONY | other | 0 |
| Mar 18, 26 | Chhoa Darren Yen Feng | other | 0 |
| Mar 18, 26 | Tan Boon Chye | other | 0 |
| Mar 18, 26 | Fung Keng Leong | other | 0 |
| Feb 18, 25 | FREUDENTHALER PAUL D | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BMGL coverage
Recent articles, reports, and earnings notes.
No research on BMGL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BMGL report →BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
globenewswire.com · Jul 10
BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
globenewswire.com · Jul 10
QingSong Health Corp (2661.HK) and Basel Medical Sign Strategic Cooperation Memorandum to Explore AI Healthcare Services in Southeast Asia
prnewswire.com · Jun 10
BMGL to Effect Reverse Share Split on June 22, 2026
globenewswire.com · Jun 10
BMGL to Effect Reverse Share Split on June 22, 2026
globenewswire.com · Jun 10
BMGL Investors Have Opportunity to Join Basel Medical Group Ltd Fraud Investigation with the Schall Law Firm
globenewswire.com · Apr 23
Rosen Law Firm Encourages Basel Medical Group Ltd. Investors to Inquire About Securities Class Action Investigation – BMGL
businesswire.com · Apr 14
Rosen Law Firm Encourages Basel Medical Group Ltd. Investors to Inquire About Securities Class Action Investigation – BMGL
businesswire.com · Apr 13
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.